| 摘要 |
<p>There is provided the use of a compound of formula (I): wherein Y, W<SUP>1</SUP> to W<SUP>4</SUP>, Z<SUP>1</SUP> to Z<SUP>4</SUP> and R have meanings given in the description, and pharmaceutically-acceptable salts thereof, for the manufacture of a medicament for the treatment of a disease in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation.</p> |
| 申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH;BIOLIPOX AB;PELCMAN, BENJAMIN;OLOFSSON, KRISTOFER;KALVINS, IVARS;SUNA, EDGARS;OZOLA, VITA;SCHAAL, WESLEY |
发明人 |
PELCMAN, BENJAMIN;OLOFSSON, KRISTOFER;KALVINS, IVARS;SUNA, EDGARS;OZOLA, VITA;SCHAAL, WESLEY |
